The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium*

Robert N. Weinreb; Paul L. Kaufman

doi:10.1167/iovs.08-2843

journal article Apr 01, 2009

The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium*

Robert N. Weinreb

Paul L. Kaufman

Investigative Opthalmology & Visual Science Vol. 50 No. 4 pp. 1497 · Association for Research in Vision and Ophthalmology (ARVO)

View at Publisher Save 10.1167/iovs.08-2843

Topics

No keywords indexed for this article. Browse by subject →

Metrics

91

Citations

0

References

Details

Published: Apr 01, 2009
Vol/Issue: 50(4)
Pages: 1497

Authors

R

Robert N. Weinreb

From the Hamilton Glaucoma Center, University of California, San Diego, La Jolla, California; and the

P

Paul L. Kaufman

Department of Ophthalmology and Visual Science, University of Wisconsin, Madison, Wisconsin.

Cite This Article

Robert N. Weinreb, Paul L. Kaufman (2009). The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium*. Investigative Opthalmology & Visual Science, 50(4), 1497. https://doi.org/10.1167/iovs.08-2843

The Glaucoma Research Community and FDA Look to the Future: A Report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium*

You May Also Like